Heidi
Grundt
Associate professor II
Visit Address:
Haukeland universitetssykehus, Laboratoriebygget
5021 Bergen
Postal Address:
Postboks 7804
5021 Bergen
Phone:
+47 51 51 80 00
E-mail:
Journal articles
- 2014. Re-admissions to hospital and patient satisfaction among patients with chronic obstructive pulmonary disease after telemedicine video consultation - A retrospective pilot study. Multidisciplinary Respiratory Medicine. 9:6. doi: 10.1186/2049-6958-9-6
- 2013. Long-term prognostic utility of PAPP-A and calprotectin in suspected acute coronary syndrome. Scandinavian Cardiovascular Journal. 47: 88-97. doi: 10.3109/14017431.2013.764571
- 2013. THE LONG PENTRAXIN 3 DID NOT PREDICT OUTCOME WITHIN 45 MONTHS FOLLOW-UP IN PATIENTS FOLLOWING A SEVERE MYOCARDIAL INFARCTION. Journal of the American College of Cardiology. 61: E185-E185. doi: 10.1016/S0735-1097(13)60186-2
- 2012. The Role of Long-Chained Marine N-3 Polyunsaturated Fatty Acids in Cardiovascular Disease. Cardiology Research and Practice. 2012. 15 pages. doi: 10.1155/2012/303456
- 2012. BNP, PTX3, and D-dimer are predictors of death, but only BNP is also a predictor of troponin-T positive cardiac events at long-term follow-up after hospitalization with acute chest pain. European Heart Journal. 33: 947-947.
- 2012. Activated factor XII type A independently predicts outcome during seven years follow-up in patients admitted with suspected acute coronary syndrome. European Heart Journal. 33: 444-444.
- 2012. Long Pentraxin 3 (PTX3), Activated Factor XII type A (XIIaA) and B-type Natriuretic Peptide (BNP) did not independently predict stroke during seven years follow-up in patients admitted with chest pain. European Heart Journal. 33: 236-236. doi: 10.1093/eurheartj/ehs284
- 2011. B-type natriuretic peptide and high sensitive C-reactive protein predict 2-year all cause mortality in chest pain patients: a prospective observational study from Salta, Argentina. BMC Cardiovascular Disorders. 11. 11 pages. doi: 10.1186/1471-2261-11-57
- 2010. A history of late and very late stent thrombosis is not associated with increased activation of the contact system, a case control study. Thrombosis Journal. 8: 6. doi: 10.1186/1477-9560-8-6
- 2010. A combination of novel biomarkers for coagulation (XIIaA), vascular inflammation (PTX3) and heart failure (BNP) enhances prognostic information in patients admitted with chest pain. European Heart Journal. 31: 803-803.
- 2009. (n-3) Fatty Acid Content of Red Blood Cells Does Not Predict Risk of Future Cardiovascular Events following an Acute Coronary Syndrome. Journal of Nutrition. 139: 507-513. doi: 10.3945/jn.108.096446
- 2009. The long pentraxin 3 (PTX3): a novel prognostic inflammatory marker for mortality in acute chest pain. Thrombosis and Haemostasis. 102: 555-563. doi: 10.1160/TH09-02-0137
- 2009. Activated factor XII type A predicts long-term mortality in patients admitted with chest pain. Journal of Thrombosis and Haemostasis. 7: 277-287. doi: 10.1111/j.1538-7836.2008.03248.x
- 2009. Activated factor XII type A and B-type natriuretic peptide are complementary and incremental predictors of mortality in patients following admission with acute coronary syndrome. Blood Coagulation and Fibrinolysis. 20: 652-660. doi: 10.1097/MBC.0b013e32832fa814
- 2008. Low levels of cellular omega-3 increase the risk of ventricular fibrillation during the acute ischaemic phase of a myocardial infarction. Resuscitation. 78: 258-264. doi: 10.1016/j.resuscitation.2008.04.007
- 2008. Holotranscobalamin and methylmalonic acid as prognostic markers following an acute myocardial infarction. European Journal of Clinical Nutrition. 62: 411-418. doi: 10.1038/sj.ejcn.1602701
- 2008. The long-term prognostic value of multiple biomarkers following a myocardial infarction. Thrombosis Research. 123: 60-66. doi: 10.1016/j.thromres.2008.01.012
- 2008. The prognostic utility of D-dimer and fibrin monomer at long-term follow-up after hospitalization with coronary chest pain. Blood Coagulation and Fibrinolysis. 19: 701-707. doi: 10.1097/MBC.0b013e32830b1512
- 2008. B-type natriuretic peptide is a long-term predictor of all-cause mortality, whereas high-sensitive C-reactive protein predicts recurrent short-term troponin T positive cardiac events in chest pain patients: a prognostic study. BMC Cardiovascular Disorders. 8. doi: 10.1186/1471-2261-8-34
- 2008. n-3 fatty acids and cardiovascular disease. Haematologica. 93: 807-812. doi: 10.3324/haematol.13191
- 2008. Comparison of the omega-3 index in the acute coronary syndromes in a beef-eating population in Argentina as compared to a fish-eating population in Norway. Circulation. 118: E439-E439. doi: 10.1161/CIRCULATIONAHA.108.189875
- 2008. Activated Factor XII Type A Predicts Long-Term Mortality in Patients Admitted with Chest Pain. Journal of Thrombosis and Haemostasis. 7: 277-287. doi: 10.1111/j.1538-7836.2008.03248.x
- 2008. Activated Factor XII type A is an independent predictor of cardiovascular outcome in coronary patients admitted with troponin T negative chest pain. Circulation. 118: E194-E195. doi: 10.1161/CIRCULATIONAHA.108.189874
- 2008. Activated Factor XII and B-type natriuretic peptide, but not C-reactive protein, are independent predictors of mortality following admission with suspected myocardial infarction. Circulation. 118: E194-E194. doi: 10.1161/CIRCULATIONAHA.108.189874
- 2007. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease. Journal of Internal Medicine. 262: 244-253. doi: 10.1111/j.1365-2796.2007.01810.x
- 2007. The effect of primary percutaneous coronary intervention as compared to tenecteplase on myeloperoxidase, pregnancy-associated plasma protein A, soluble fibrin and D-dimer in acute myocardial infarction. Thrombosis Research. 119: 415-421. doi: 10.1016/j.thromres.2006.03.009
- 2007. Changes of plasma activated Factor XII type A (XIIaA) concentrations following percutaneous coronary intervention (PCI). Journal of Thrombosis and Thrombolysis. 24: 131-135. doi: 10.1007/s11239-007-0041-9
- 2006. Long term influence of regular intake of high dose n-3 fatty acids on CD40-ligand, pregnancy-associated plasma protein A and matrix metal loproteinase-9 following acute myocardial infarction. Thrombosis and Haemostasis. 95: 329-336. doi: 10.1160/TH05-07-0497
- 2006. Specific types of activated Factor XII increase following thrombolytic therapy with tenecteplase. Journal of Thrombosis and Thrombolysis. 22: 199-203. doi: 10.1007/s11239-006-9031-6
- 2005. B-Type Natriuretic peptide is not only a predictor of death, but also of troponin-T positive cardiac events at 6 months follow-up after hospitalisation with acute chest pain. European Heart Journal. 26: 717-717.
- 2004. Interaksjon mellom hjerte- og lungesykdom. Hjerteforum. 4: 40-46.
- 2004. Interaksjon mellom hjerte- og lungesykdom. Lungeforum. 14: 25-31.
- 2004. Activated factor 12 (FXIIa) predicts recurrent coronary events after an acute myocardial infarction. American Heart Journal. 147: 260-266.
- 2004. Clinical outcome and atherothrombogenic risk profile after prolonged wash-out following long-term treatment with high doses of n-3 PUFAs in patients with an acute myocardial infarction. Clinical Nutrition. 23: 491-500.
- 2004. Activated factor XII predicts troponin-T positive cardiac events at 30 days follow-up after hospitalization with acute chest pain. Circulation. 110.
- 1999. Atherothrombogenic risk modulation by n-3 fatty acids was not associated with changes in homocysteine in subjects with combined hyperlipidaemia. Thrombosis and Haemostasis. 81: 561-565.
Reports and theses
- 2004. Risk evaluation in atherothrombogenic populations receiving a high dose of n-3 fatty acids, with special reference to homocysteine, tissue factor, activated factor XII and peroxidation. 92 pages.
More information in national current research information system (CRIStin)